BLFS
BioLife Solutions Inc
36.70$
-0.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.2% | +27.6% | +34.0% | +79.1% | +38.6% | +75.7% | +147.8% | -36.0% | -10.8% | +20.9% | +17.0% | |
| – | -16.5% | +30.9% | +24.0% | +45.4% | +58.3% | +140.7% | +246.8% | -64.3% | -9.0% | +7.1% | +19.3% | |
| – | +25.7% | +25.3% | +41.2% | +100.5% | +29.6% | +39.2% | +51.8% | +26.6% | -11.9% | +29.9% | +15.7% | |
| – | +58.3% | +47.2% | -41.2% | +8.8% | +217.4% | +63.1% | +75.9% | +25.2% | -62.7% | +43.5% | -4.4% | |
| – | +22.6% | -5.7% | -1.5% | +31.5% | +49.5% | +64.3% | +130.5% | -1.2% | +28.7% | -5.3% | +12.3% | |
| – | +43.1% | +9.0% | -19.0% | +26.4% | +93.9% | +45.1% | +144.0% | -22.0% | +14.9% | +0.1% | +3.5% | |
| – | – | – | – | – | -106.0% | – | – | – | – | – | – | |
| – | -87.7% | +1,363.7% | -40.3% | -97.4% | +0.0% | +260.0% | +2,594.4% | +41.6% | +163.8% | -60.3% | +276.4% | |
| – | – | – | – | – | -197.9% | – | – | – | – | – | – | |
| – | – | – | -10.0% | -72.9% | -489.1% | – | – | – | – | – | – | |
| – | – | – | – | – | -150.7% | – | -434.0% | – | – | – | – | |
| – | – | – | – | – | -35.8% | -3.7% | -819.1% | – | – | – | +135.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.